An investigation of the pharmacokinetics, toxicity, and clinical efficacy of Neoral cyclosporin in cystic fibrosis patients.
Mikhail
G
G
Department of Cardiothoracic Surgery, National Heart and Lung Institute, Harefield Hospital, Middlesex, UK.
Eadon
H
H
Leaver
N
N
Rogers
P
P
Stephens
D
D
Banner
N
N
Khaghani
A
A
Yacoub
M
M
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D002648:Child; D016572:Cyclosporine / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D003550:Cystic Fibrosis / Q000601:surgery*; D005260:Female; D005541:Forced Expiratory Volume; D006084:Graft Rejection / Q000453:epidemiology; D016041:Heart-Lung Transplantation / Q000276:immunology* / Q000502:physiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D015994:Incidence; D016040:Lung Transplantation / Q000276:immunology* / Q000502:physiology; D008297:Male; D014797:Vital Capacity
D007166:Immunosuppressive Agents; D016572:Cyclosporine